Antibody Purification Services Market Analysis

  • Report ID: 5923
  • Published Date: Sep 16, 2025
  • Report Format: PDF, PPT

Antibody Purification Services Market Segmentation:

Type Segment Analysis

The antigen-specific affinity segment is expected to hold around 47% share of the global antibody purification services market by 2035.because of the rising demand for antigen-specific affinity in various applications. Based on the interaction between particular immobilized ligands and target antibodies, antigens, and so forth, affinity chromatography is an effective approach for separating antibodies, antigens, and proteins. Antibodies or their Fab fragments can be separated using populations of available ligands. Immunoaffinity chromatography (IAC) on low-affinity immobilized antibodies can also be used to isolate antigens. The natural affinity proteins of bacteria, like pA and pG, were the most often utilized when IgG affinity proteins were first created for use in antibody purification. Macromolecules and antibodies have a molecular weight of about 150 kDa. Antigen-binding fragment (Fab) and crystallizable fragment (Fc) combine to produce an antibody molecule, which has a "Y" shape.

Antibody Type Segment Analysis

The monoclonal antibodies segment is expected to hold around 74% share of the global antibody purification services market by 2035 owing to the increasing financing on the research on monoclonal antibodies to create new therapeutics across the world. 2019 saw mAbs for inflammatory and cancerous conditions account for seven of the ten best-selling new medications. The US, Europe, and Canada account for 80% of the global market for mAb sales. 85% of the world's population lives in the rest of the world, while just 20% of mAbs are sold. Products containing monoclonal antibodies have emerged from relative obscurity in the 1990s to a position where they increasingly control patient impact and revenue creation. The past 20 years have seen a significant portion of this accomplishment, and we have pinpointed elements linked to the astounding developments that have aided in the identification, creation, and acceptance of monoclonal antibodies.

Our in-depth analysis of the global antibody purification services market includes the following segments:

          Type

  • Physiochemical Fractionation
  • Class-Specific Affinity
  • Antigen-Specific Affinity

          Antibody Type

  • Monoclonal Antibodies
  • Polyclonal Antibodies
  • Recombinant Antibodies

          End-Use Industry

  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Companies
  • Contract Research Organizations

          Service Type

  • Antibody Development
  • Antibody Production
  • Downstream Antibody Services
  • Antibody Purification Services
  • Antibody Fragmentation
  • Conjugation

          Source

  • Rabbit
  • Chicken
  • Guinea pig
  • Goat
  • Mouse
  • Rat

          Application

  • Oncology
  • Infectious diseases
  • Immunology
  • Neurobiology
  • Stem cells
  • Cardiovascular Disease

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of antibody purification services is assessed at USD 2.53 billion.

The global antibody purification services market size surpassed USD 2.35 billion in 2025 and is projected to witness a CAGR of around 8.5%, crossing USD 5.31 billion revenue by 2035.

The North America antibody purification services market achieves a 38% share by 2035, fueled by the increasing prevalence of cardiovascular diseases in this region.

Key players in the market include Antibody Research Corporation, Thermo Fisher, Detai Bio-tech Co., Genscript, KMD Bioscience, Southern Biotech, GE Healthcare, COVALAB, Creative Biolabs, Abcam, Chugai Pharmaceutical Co., Ltd., Medicinal Chemistry Pharmaceutical Co., Ltd., Mitsubishi Chemical Group Corp.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos